DIVISLAB Share Price Target 2030

CAGR-based price projection for Divi's Laboratories Limited (DIVISLAB) targeting 2030, derived from official NSE exchange closing prices.

Bear Case (20.5% CAGR)
Rs 19,491
2030 Target
Base Case (51.2% CAGR)
Rs 48,357
2030 Target
Bull Case (167.3% CAGR)
Rs 471,833
2030 Target

Current Market Snapshot

CMP: Rs 9,249.00
52W High: Rs 9,624.00
52W Low: Rs 6,070.00
1Y CAGR: 128.7%
3Y CAGR: 51.2%

Year-by-Year Price Projection

YearBear CaseBase CaseBull Case
2027 Rs 11,144 Rs 13,986 Rs 24,718
2028 Rs 13,427 Rs 21,148 Rs 66,060
2029 Rs 16,177 Rs 31,979 Rs 176,549
2030 Rs 19,491 Rs 48,357 Rs 471,833

Other DIVISLAB Price Targets

2025 2026 2027 2028 2035 2040 2050

Frequently Asked Questions

What is the DIVISLAB share price target for 2030?

Based on historical growth analysis, the DIVISLAB share price target for 2030 ranges from Rs 19,491 (conservative) to Rs 48,357 (base case) to Rs 471,833 (optimistic). These projections are based on trailing CAGR and should not be treated as guaranteed outcomes.

What is the current share price of DIVISLAB?

The current market price of DIVISLAB (Divi's Laboratories Limited) is Rs 9,249.00. The 52-week high is Rs 9,624.00 and 52-week low is Rs 6,070.00.

Is DIVISLAB a good stock to buy for the long term?

Long-term investment decisions depend on individual risk tolerance, financial goals, and portfolio diversification. Examine the company's fundamentals, debt-to-equity ratio, promoter holding, and competitive positioning within its sector. BrokerLens provides data-driven analysis; consult a SEBI-registered financial advisor before investing.

What methodology does BrokerLens use for DIVISLAB price targets?

BrokerLens computes price targets using historical Compound Annual Growth Rate (CAGR) derived from official NSE closing prices. Three scenarios are modeled: Bear (conservative at 20.5% CAGR), Base (51.2% CAGR), and Bull (optimistic at 167.3% CAGR). These are statistical projections, not guaranteed forecasts.

Disclaimer: Share price targets on BrokerLens are statistical CAGR projections based on historical NSE closing prices. They are NOT guaranteed outcomes, investment advice, or analyst recommendations. Past performance does not guarantee future results. Consult a SEBI-registered investment advisor before making investment decisions. Mutual fund and equity investments are subject to market risks.